Price of medicines to go up from April 1; bypass stent price by Rs 165
Thrissur: As a result of the change in the annual wholesale price index (WPI), the price of essential medicines will slightly increase from April 1 onwards. The price of about 900 medicines will rise by 0.53638 percent. The cost of medicated heart stents that is used to clear blocks in blood vessels will increase by Rs 165. Also various IV fluids will become costlier.
The essential medicines are decided as per the situations in each country. In India, the medicines that fall under the category of E are subjected to price control. The regulated price of these medicines will be revised annually on the basis of the WPI. The price has been going up in the past three years. But it had declined one year before that following decrease in the WPI.
The Ministry of Commerce and Industries prepares the WPI of the previous year. The index is prepared in comparison to the previous market rate. According to the drug price control order, the price of essential medicines can be revised on the basis of WPI.
As per the new index, Rs 165 will be increased for the high grade bypass stents that cost Rs 30,647 and the revised price will touch Rs 30,812. Bare-metal stent price will go up from Rs 8417 to Rs 8462.
Though the price hike is on a marginal rate, it will become a burden in the case of expensive medicines. For example, Trastuzumab injection used for treating cancer costs Rs 59,976.96 at present. This will rise to Rs 60,299 after revision.
The price hike will mostly affect patients with lifestyle diseases like diabetes, blood pressure and heart diseases. Their monthly budget will be easily affected by even the slightest hike in prices, especially due to the post-COVID crisis.